Hodogaya Chemical Co., Ltd.
Stock Price Chart
2026/11/18 13:39 UpdatedPrice Trend
2026/11/18 13:39 UpdatedPrice & Trading Details
2026/11/18 13:39 UpdatedPRICE
TRADING
Earnings Calendar
Updated 2026/11/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2016/01/28 | ¥6.73 | ¥6.00 | -10.8% |
| 2015/07/30 | ¥17.70 | ¥-8.70 | -149.1% |
| 2015/05/10 | ¥1.54 | ¥34.30 | +2,134.5% |
| 2015/01/29 | ¥-7.72 | ¥9.55 | +223.6% |
Shareholder Composition
Updated 2026/11/01Top Mutual Funds / ETFs
Updated 2026/11/01Major Holders
Updated 2026/11/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
158.2K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-DFA Intl SMALL CAP VALUE PORT.
|
129.3K | +1.09% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
105.4K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. PORT.
|
55.4K | 0.00% | |
|
DFA INVESTMENT TRUST CO-THE JAPANESE SMALL COMPANY SERIES
|
49.2K | 0.00% | |
|
Dimensional ETF Trust-Dimensional International Small Cap Value ETF
|
49.0K | +1.02% |
Dividend History 4Years Growth
Updated 2026/11/15| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥55 | +15.8% |
| 2025 | ¥48 | +15.2% |
| 2024 | ¥41 | +17.9% |
| 2023 | ¥35 | +12.0% |
| 2022 | ¥31 | - |
Financial Performance
2026/11/15 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥43,324M | ¥44,261M | ¥48,578M | ¥48,040M |
| Gross Profit | ¥16,669M | ¥17,099M | ¥19,200M | ¥18,762M |
| Operating Income | ¥3,705M | ¥3,958M | ¥4,884M | ¥3,718M |
| Pretax Income | ¥4,323M | ¥4,768M | ¥4,913M | ¥4,706M |
| Net Income | ¥2,223M | ¥2,480M | ¥3,178M | ¥3,054M |
| EPS | ¥140.32 | ¥156.32 | ¥200.04 | ¥192.07 |
| Operating Margin | 8.55% | 8.94% | 10.05% | 7.74% |
| Balance Sheet | ||||
| Total Assets | ¥72,051M | ¥81,157M | ¥79,858M | ¥86,413M |
| Total Equity | ¥42,834M | ¥47,733M | ¥48,599M | ¥52,580M |
| Total Liabilities | ¥29,217M | ¥33,424M | ¥31,259M | ¥33,833M |
| Cash | ¥10,487M | ¥12,965M | ¥10,774M | ¥10,137M |
| Interest-bearing Debt | ¥11,079M | ¥9,811M | ¥8,787M | ¥9,495M |
| Equity Ratio | 59.45% | 58.82% | 60.86% | 60.85% |
| D/E Ratio | 0.26 | 0.21 | 0.18 | 0.18 |
| Cash Flow | ||||
| Operating CF | ¥1,058M | ¥8,343M | ¥5,669M | ¥6,092M |
| Investing CF | -¥7,036M | -¥3,950M | -¥6,548M | -¥5,026M |
| Financing CF | ¥2,288M | -¥2,067M | -¥1,882M | -¥694M |
| Free CF | -¥2,058M | ¥2,988M | ¥248M | -¥254M |
| Efficiency | ||||
| ROE | 5.19% | 5.20% | 6.54% | 5.81% |
| ROA | 3.09% | 3.06% | 3.98% | 3.53% |
Latest IR Information
-
Fiscal 2026 Q2 Financial Summary (Consolidated)
Consolidated results for H1 FY2026: net sales 26,587 million yen, operating income 3,407 million yen, ordinary income 3,561 million yen, interim net income attributable to owners of parent 1,539 million yen. Year-on-year net sales increased by 4,041 million yen (+17.9%),...
Read more -
Fiscal Year Ending March 2027 — Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)
For the second quarter of the fiscal year ending March 2027, net sales were 26,587 million yen (Year-over-Year +17.9%), operating income was 3,407 million yen (+122.3%). Ordinary income was 3,561 million yen and interim net income attributable to owners of...
Read more -
Notice of Revision to Full-Year Earnings Forecast
Revised upward the full-year (2026/4/1-2027/3/31) earnings forecast. Net sales increased by 2,000 million yen from the previous forecast, operating income by 1,500 million yen, ordinary income by 1,200 million yen, net income attributable to owners of parent by 300 million...
Read more -
Notice Regarding Approval for Listing of Shares of Consolidated Korean Subsidiary
SFC obtained approval for a new listing on the Korean KA market KOSPI. The company plans to accelerate production capacity expansion and talent acquisition through fundraising from the listing to enhance group value. The listing timing will be announced separately...
Read more -
Announcement Regarding Establishment of a Subsidiary
To promote the nucleic acid therapeutics CDMO business, establish subsidiary NuChord (as of September 1, 2026, capital 200 million yen, 100% equity). Build a one-stop production system utilizing the new building and cleanrooms at the Koriyama Plant, aiming to provide...
Read more
Latest News (5 items)
Company Information
About
Hodogaya Chemical Co., Ltd. primarily engages in the production and sale of organic industrial chemicals in Japan. The company operates through five segments: Functional dyes, Functional Resins, Basic Chemicals, Agroscience, and Logistics. The Functional dyes segment offers charge control agents for toners, organic photoconductor materials, organic EL materials, Biomaterials, various dyes, etc. The Functional resins segment provides urethane raw materials, adhesives, release agents urethane-based materials for various building and timber applications, waterproofing and water-stopping work and various intermediates for pharmaceutical resin materials and electronic materials. The Basic Chemicals segment offers Hydrogen peroxide and its derivatives, and other basic industrial raw materials. The Agroscience segment provides herbicides, insecticides, oxygen supply agents. The Logistics segment offers warehousing, cargo handling, iso tank container storage. The company was formerly known as Hodogaya Soda Co., Ltd. and changed its name to Hodogaya Chemical Co., Ltd. in 1939. Hodogaya Chemical Co., Ltd. was incorporated in 1916 and is headquartered in Tokyo, Japan.